ROSS GEORGE K
SEC insider (Form 3/4/5 filer). CIK 0001068724. Director at ACURA PHARMACEUTICALS, INC (ACUR). 4 reported Form 4/5 transactions since Sep 2024; latest on Jan 2, 2026. Located in PALATINE, IL.
Companies ROSS GEORGE K has filed insider reports for
- ACURA PHARMACEUTICALS, INC (ACUR): Director
ROSS GEORGE K
CIK: 0001068724
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ACURA PHARMACEUTICALS, INC
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jan 2, 2026ACUR
ACURA PHARMACEUTICALS, INC
ExerciseDirect50K shares- - Jan 2, 2026ACUR
ACURA PHARMACEUTICALS, INC
AwardDirectRestricted Stock Units (2021 Plan)
50K shares- - Jan 2, 2025ACUR
ACURA PHARMACEUTICALS, INC
ExerciseDirect50K shares- - Jan 2, 2025ACUR
ACURA PHARMACEUTICALS, INC
AwardDirectRestricted Stock Units (2021 Plan)
50K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 2, 2026 | ACUR ACURA PHARMACEUTICALS, INC | Exercise | 50,000 | - | $0 | Direct |
| Jan 2, 2026 | ACUR ACURA PHARMACEUTICALS, INC | Award Restricted Stock Units (2021 Plan) | 50,000 | - | - | Direct |
| Jan 2, 2025 | ACUR ACURA PHARMACEUTICALS, INC | Exercise | 50,000 | - | $0 | Direct |
| Jan 2, 2025 | ACUR ACURA PHARMACEUTICALS, INC | Award Restricted Stock Units (2021 Plan) | 50,000 | - | - | Direct |
1-4 of 4 transactions